{"component":{"type":17,"accent_color":3123338,"components":[{"type":10,"content":"-# WikiRNG · Roll of 11/1/2026 · by [flamingoinvasion](https://wikirng.com/u/flamingoinvasion)"},{"type":10,"content":"## [Figitumumab](https://wikirng.com/roll/0Y63E4)\n*Chemical compound*"},{"type":10,"content":">>> Figitumumab (previously CP-751871) is a monoclonal antibody targeting the insulin-like growth factor-1 receptor that was investigated for the treatment of various types of cancer, for example adrenocortical carcinoma and non-small cell lung cancer (NSCLC)."},{"type":14,"divider":true,"spacing":1},{"type":10,"content":"### 🟩 Notable · 70,323 SP\n-# Top 30%"},{"type":14,"divider":true,"spacing":1},{"type":10,"content":"🟦 🧁 **Wikiversary** · Obscure · +36,186 SP\n-# Created on today's date, any year.\n🟩 🛰️ **Reuters** · Notable · +9,499 SP\n-# Links to Reuters.\n🟩 🦓 **Zebra** · Notable · +6,937 SP\n-# The title's letters alternate vowel and consonant (7+ letters).\n🟩 🛞 **Hub** · Notable · +3,112 SP\n-# 500+ articles link here.\n🟩 🧬 **PubMed** · Notable · +3,089 SP\n-# Links to PubMed.\n🟩 📻 **The BBC** · Notable · +2,551 SP\n-# Links to the BBC.\n-# +16 more badges"},{"type":14,"divider":true,"spacing":1},{"type":1,"components":[{"type":2,"style":5,"label":"View roll","url":"https://wikirng.com/roll/0Y63E4"},{"type":2,"style":5,"label":"Read on Wikipedia","url":"https://en.wikipedia.org/wiki/Figitumumab"}]},{"type":10,"content":"-# Article text from Wikipedia, CC BY-SA 4.0"}]}}